chr10-103368407-G-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006951.5(TAF5):c.418G>A(p.Gly140Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000249 in 1,567,198 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006951.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000593 AC: 9AN: 151722Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000403 AC: 7AN: 173602 AF XY: 0.0000103 show subpopulations
GnomAD4 exome AF: 0.0000212 AC: 30AN: 1415476Hom.: 1 Cov.: 35 AF XY: 0.0000142 AC XY: 10AN XY: 702038 show subpopulations
GnomAD4 genome AF: 0.0000593 AC: 9AN: 151722Hom.: 0 Cov.: 33 AF XY: 0.0000540 AC XY: 4AN XY: 74118 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.418G>A (p.G140S) alteration is located in exon 1 (coding exon 1) of the TAF5 gene. This alteration results from a G to A substitution at nucleotide position 418, causing the glycine (G) at amino acid position 140 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at